TY - JOUR
T1 - Observations of periwound skin protection in venous ulcers
T2 - A comparison of treatments
AU - Hunter, Susan M.
AU - Langemo, Diane
AU - Thompson, Patricia
AU - Hanson, Darlene
AU - Anderson, Julie
AU - Oh, In Eui
AU - Paulson, Rolf
AU - Rustvang, Dan
AU - Dorman, Seth
AU - Roth, David L.
PY - 2013/2
Y1 - 2013/2
N2 - OBJECTIVE: The objective of this study was to examine the effectiveness of 2 products on venous ulcer periwound skin. DESIGN: This was a descriptive comparative study. SETTING: An outpatient wound care clinic in a rural Midwestern area of the United States. PARTICIPANTS: Participants included a retrospective group of 50 patients and a prospective group of 28 patients. INTERVENTION: The intervention compared the experimental product (Remedy Nutrashield; Medline Industries, Mundelein, Illinois) versus Cavilon Moisturizing Lotion (3M, St Paul, Minnesota). OUTCOMME MEASURES: The mean outcome measures were a decrease in periwound and ulcer size. MAIN RESULTS: For the periwound size, the estimated rates of change were as follows: 0.092 (SE, 0.021) cm/d and -0.026 (SE, 0.014) cm/d for products B and A groups, respectively. The decrease for the experimental group was significantly greater than the attenuated decrease for the retrospective cases (t297 = -2.57, P =.01), and the decrease for product B group was also significantly different from zero (t76 = -4.34, P <.0001). For the ulcer size model, the estimated rates of change were -0.272 (SE, 0.102) cm2/d and -0.130 (SE, 0.067) cm2/d for the experimental and retrospective groups, respectively. The rate for the experimental group was significantly less than zero (t76 = -2.67, P =.009), but there was no significant difference between prospective and retrospective cases in the rates of reduction in ulcer size (t308 = -1.16, P =.25). CONCLUSION: The results of this study illustrate how the integrity of the periwound skin may be an important determinant in decreasing periwound and ulcer size.
AB - OBJECTIVE: The objective of this study was to examine the effectiveness of 2 products on venous ulcer periwound skin. DESIGN: This was a descriptive comparative study. SETTING: An outpatient wound care clinic in a rural Midwestern area of the United States. PARTICIPANTS: Participants included a retrospective group of 50 patients and a prospective group of 28 patients. INTERVENTION: The intervention compared the experimental product (Remedy Nutrashield; Medline Industries, Mundelein, Illinois) versus Cavilon Moisturizing Lotion (3M, St Paul, Minnesota). OUTCOMME MEASURES: The mean outcome measures were a decrease in periwound and ulcer size. MAIN RESULTS: For the periwound size, the estimated rates of change were as follows: 0.092 (SE, 0.021) cm/d and -0.026 (SE, 0.014) cm/d for products B and A groups, respectively. The decrease for the experimental group was significantly greater than the attenuated decrease for the retrospective cases (t297 = -2.57, P =.01), and the decrease for product B group was also significantly different from zero (t76 = -4.34, P <.0001). For the ulcer size model, the estimated rates of change were -0.272 (SE, 0.102) cm2/d and -0.130 (SE, 0.067) cm2/d for the experimental and retrospective groups, respectively. The rate for the experimental group was significantly less than zero (t76 = -2.67, P =.009), but there was no significant difference between prospective and retrospective cases in the rates of reduction in ulcer size (t308 = -1.16, P =.25). CONCLUSION: The results of this study illustrate how the integrity of the periwound skin may be an important determinant in decreasing periwound and ulcer size.
KW - Periwound
KW - Skin protectant
KW - Venous ulcer
UR - http://www.scopus.com/inward/record.url?scp=84876251904&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84876251904&partnerID=8YFLogxK
U2 - 10.1097/01.ASW.0000426714.57540.c4
DO - 10.1097/01.ASW.0000426714.57540.c4
M3 - Article
C2 - 23337645
AN - SCOPUS:84876251904
SN - 1527-7941
VL - 26
SP - 62
EP - 66
JO - Advances in Skin and Wound Care
JF - Advances in Skin and Wound Care
IS - 2
ER -